Part D Success Will Enhance Pharma’s Political Effectiveness, Execs Predict

The pharmaceutical industry will draw on its achievements in helping develop the Medicare drug benefit as it faces health care reform and other political challenges following the upcoming presidential election, top Merck and Schering-Plough executives predict